Trinity Biotech (TRIB) Return on Capital Employed (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Return on Capital Employed of 31.0% for Q4 2024, up 2720.0% year-on-year from 1.1% in Q1 2024, and down 56.6% on a QoQ basis from 19.79% in Q3 2024.
Trinity Biotech (TRIB) Return on Capital Employed (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Return on Capital Employed for 16 consecutive years, with 31.0% the latest figure, recorded in Q4 2024.
- Quarterly Return on Capital Employed rose 2720.0% year-over-year to 31.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 31.0% (up 2720.0% YoY) and the FY2025 annual result came in at 42.69%, up 8565.0% from the prior year.
- Return on Capital Employed declined to 31.0% in Q4 2024 per TRIB's latest filing, from 19.79% in the prior quarter.
- Over the last five years, Return on Capital Employed for TRIB reached as high as 86.72% in Q2 2021 and fell as low as 58.2% in Q4 2023.
- A 5-year average of 5.08% and a median of 5.91% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed soared 8204 bps — and 2022, when it sank 8644 bps.
- Year by year, Return on Capital Employed stood at 19.16% in 2020, then soared by 70 bps to 32.57% in 2021, then sank by 177 bps to 24.92% in 2022, then tumbled by 134 bps to 58.2% in 2023, then surged by 47 bps to 31.0% in 2024.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 31.0%, 19.79%, and 23.09% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -31.00% |
| Sep 30, 2024 | -19.79% |
| Jun 30, 2024 | -23.09% |
| Mar 31, 2024 | -50.28% |
| Dec 31, 2023 | -58.20% |
| Sep 30, 2023 | -57.08% |
| Jun 30, 2023 | -52.47% |
| Mar 31, 2023 | -29.22% |
| Dec 31, 2022 | -24.92% |
| Sep 30, 2022 | -12.11% |
| Jun 30, 2022 | 0.29% |
| Mar 31, 2022 | 2.42% |
| Dec 31, 2021 | 32.57% |
| Sep 30, 2021 | 72.48% |
| Jun 30, 2021 | 86.72% |
| Mar 31, 2021 | 21.40% |
| Dec 31, 2020 | 19.16% |
| Sep 30, 2020 | 11.64% |
| Jun 30, 2020 | 4.68% |
| Mar 31, 2020 | 5.25% |